Trinity Biotech (TRIB) Short Interest Ratio & Short Volume $1.30 -0.02 (-1.52%) (As of 11/20/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Trinity Biotech Short Interest DataTrinity Biotech (TRIB) has a short interest of 94,100 shares, representing 0.86% of the float (the number of shares available for trading by the public). This marks a -23.06% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 165,690 shares to cover all short positions.Current Short Interest94,100 sharesPrevious Short Interest122,300 sharesChange Vs. Previous Month-23.06%Dollar Volume Sold Short$165,616.00Short Interest Ratio0.1 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares7,620,000 sharesFloat Size10,960,000 sharesShort Percent of Float0.86%Today's Trading Volume44,771 sharesAverage Trading Volume165,690 sharesToday's Volume Vs. Average27% Short Selling Trinity Biotech? Sign up to receive the latest short interest report for Trinity Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTRIB Short Interest Over TimeTRIB Days to Cover Over TimeTRIB Percentage of Float Shorted Over Time Ad DarwinNew Year, New Opportunity! 2 AI Stocks Under $10 Ready to SoarAs we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! Trinity Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202494,100 shares $165,616.00 -23.1%0.9%0.1 $1.76 10/15/2024122,300 shares $205,720.83 +22.3%1.1%0.1 $1.68 9/30/2024100,000 shares $110,000.00 +11.5%0.9%0.1 $1.10 9/15/202489,700 shares $143,520.00 -57.9%0.8%0.1 $1.60 8/31/2024213,200 shares $424,268.00 +1,232.5%1.8%0.2 $1.99 8/15/202416,000 shares $36,800.00 -25.6%0.2%0.3 $2.30 Get the Latest News and Ratings for TRIB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter. 7/31/202421,500 shares $64,070.00 +16.9%0.3%0.4 $2.98 7/15/202418,400 shares $56,304.00 +70.4%0.3%0.4 $3.06 6/30/202410,800 shares $23,004.00 -71.5%0.2%0.2 $2.13 6/15/202437,900 shares $105,362.00 +213.2%0.5%0.9 $2.78 5/31/202412,100 shares $20,328.00 +63.5%0.2%0.5 $1.68 5/15/20247,400 shares $11,248.00 +516.7%0.1%0.4 $1.52 4/30/20241,200 shares $2,184.00 -36.8%0.0%0.1 $1.82 4/15/20241,900 shares $3,629.00 +58.3%0.0%0 $1.91 3/31/20241,200 shares $2,448.00 -72.1%0.0%0 $2.04 3/15/20244,300 shares $9,718.00 -71.9%0.1%0 $2.26 2/29/202415,300 shares $33,354.00 -5.0%0.2%0.2 $2.18 2/15/202416,100 shares $41,135.50 -46.9%N/A0.2 $2.56 1/31/202430,300 shares $17,877.00 +3.1%N/A0.1 $0.59 1/15/202429,400 shares $14,112.00 +92.2%N/A0.6 $0.48 12/31/202315,300 shares $6,563.70 -72.6%N/A0.3 $0.43 12/15/202355,800 shares $27,844.20 -14.6%N/A1.2 $0.50 11/30/202365,300 shares $31,148.10 +9.4%N/A1.8 $0.48 11/15/202359,700 shares $25,611.30 +70.1%N/A2.2 $0.43 10/31/202335,100 shares $16,146.00 +9.4%N/A1.3 $0.46 10/15/202332,100 shares $16,820.40 +23.0%N/A0.8 $0.52 9/30/202326,100 shares $19,186.11 +6.1%N/A0.6 $0.74 9/15/202324,600 shares $17,736.60 -1.6%N/A0.4 $0.72 8/31/202325,000 shares $20,000.00 +20.2%N/A0.4 $0.80 8/15/202320,800 shares $14,913.60 -59.9%N/A0.3 $0.72 7/31/202351,800 shares $49,210.00 +3.2%N/A0.8 $0.95 7/15/202350,200 shares $42,670.00 +27.4%N/A0.8 $0.85 6/30/202339,400 shares $37,473.34 -8.4%N/A0.8 $0.95 6/15/202343,000 shares $44,720.00 +91.1%N/A1 $1.04 5/31/202322,500 shares $20,925.00 -23.5%N/A0.5 $0.93 5/15/202329,400 shares $27,606.60 -18.3%N/A0.8 $0.94 4/30/202336,000 shares $37,972.80 -6.7%N/A1.1 $1.05 4/15/202338,600 shares $32,427.86 +33.1%N/A1.3 $0.84 3/31/202329,000 shares $27,260.00 -23.1%N/A1.2 $0.94 3/15/202337,700 shares $36,188.23 +10.9%N/A1.5 $0.96JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. 2/28/202334,000 shares $35,870.00 -11.9%N/A1.3 $1.06 2/15/202338,600 shares $41,109.00 -1.5%N/A1.5 $1.07 1/31/202339,200 shares $42,140.00 -35.3%N/A1.3 $1.08 1/15/202360,600 shares $64,236.00 -19.8%N/A1.8 $1.06 12/30/202275,600 shares $74,844.00 -5.4%N/A2.3 $0.99 12/15/202279,900 shares $92,684.00 -23.8%N/A2.4 $1.16 11/30/2022104,900 shares $139,517.00 -22.0%N/A3.2 $1.33 11/15/2022134,400 shares $178,752.00 -2.9%N/A3.7 $1.33 10/31/2022138,400 shares $160,544.00 -17.1%N/A4.2 $1.16 10/15/2022166,900 shares $198,627.69 -12.7%N/A4.7 $1.19 9/30/2022191,200 shares $204,775.20 -12.1%N/A5.2 $1.07 9/15/2022217,400 shares $256,532.00 -13.9%N/A5.3 $1.18 8/31/2022252,500 shares $308,050.00 -13.4%N/A5.8 $1.22 8/15/2022291,700 shares $402,546.00 -19.6%N/A6.1 $1.38 7/31/2022362,800 shares $493,408.00 -19.8%N/A5.9 $1.36 7/15/2022452,600 shares $624,588.00 +1.0%N/A4.7 $1.38 6/30/2022448,100 shares $551,163.00 -6.4%N/A0.7 $1.23 6/15/2022478,700 shares $588,801.00 +2.9%N/A0.7 $1.23 5/31/2022465,100 shares $660,442.00 +10.6%N/A0.7 $1.42 5/15/2022420,600 shares $492,102.00 +1.8%N/A0.6 $1.17 4/30/2022413,100 shares $491,589.00 -34.1%N/A0.6 $1.19 4/15/2022626,900 shares $764,818.00 +246.0%N/A0.9 $1.22 3/31/2022181,200 shares $192,072.00 -23.2%N/A1.4 $1.06 3/15/2022235,800 shares $231,060.42 +6.5%N/A1.8 $0.98 2/28/2022221,400 shares $225,828.00 +32.1%N/A1.5 $1.02 2/15/2022167,600 shares $191,064.00 -20.2%N/A1.2 $1.14 1/31/2022210,100 shares $241,615.00 -73.4%N/A1.8 $1.15 1/15/2022790,500 shares $1.09 million +36.5%N/A7.2 $1.39 12/31/2021579,200 shares $828,256.00 +103.8%N/A5.4 $1.43 12/15/2021284,200 shares $477,456.00 -7.3%N/A2.6 $1.68 11/30/2021306,400 shares $566,840.00 +4.2%N/A2.8 $1.85 11/15/2021294,000 shares $585,060.00 -9.4%N/A2.6 $1.99 10/29/2021324,600 shares $668,676.00 +10.5%N/A2.5 $2.06 10/15/2021293,900 shares $596,617.00 +5.2%N/A1.8 $2.03 9/30/2021279,300 shares $603,288.00 +0.0%N/A1.3 $2.16 9/15/2021279,200 shares $664,496.00 -14.9%N/A1.4 $2.38 8/31/2021327,900 shares $855,819.00 +23.4%N/A1.6 $2.61 8/13/2021265,700 shares $581,883.00 -0.2%N/A1.4 $2.19 7/30/2021266,300 shares $583,197.00 +4.6%1.3%1 $2.19 7/15/2021254,500 shares $521,725.00 -10.1%1.2%1 $2.05 6/30/2021283,200 shares $832,608.00 -1.9%1.4%1.3 $2.94 6/15/2021288,800 shares $901,056.00 -13.7%1.4%1 $3.12 5/28/2021334,700 shares $1.05 million +19.7%1.6%1.1 $3.13 5/14/2021279,600 shares $939,456.00 -18.0%1.4%0.8 $3.36 4/30/2021340,900 shares $1.17 million -17.7%1.7%1.1 $3.43 4/15/2021414,200 shares $1.61 million +13.5%2.0%0.8 $3.88 3/31/2021364,900 shares $1.44 million -3.0%1.8%0.7 $3.95 3/15/2021376,300 shares $1.73 million +45.8%1.8%0.8 $4.61 2/26/2021258,100 shares $1.36 million +59.1%N/A0.6 $5.28 2/12/2021162,200 shares $981,310.00 +22.0%0.8%0.3 $6.05JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. 1/29/2021133,000 shares $573,230.00 +4.7%N/A0.3 $4.31 1/15/2021127,000 shares $514,350.00 -15.3%N/A0.4 $4.05 12/31/2020150,000 shares $582,000.00 +32.4%N/A0.5 $3.88 12/15/2020113,300 shares $491,722.00 +0.7%N/A0.4 $4.34 11/30/2020112,500 shares $497,250.00 +72.0%N/A0.3 $4.42 11/15/202065,400 shares $197,508.00 +15.8%N/A0.2 $3.02 10/30/202056,500 shares $155,940.00 +52.7%N/A0.1 $2.76 10/15/202037,000 shares $96,570.00 +56.8%N/A0.1 $2.61 9/30/202023,600 shares $47,672.00 -62.1%N/A0 $2.02 9/15/202062,300 shares $141,421.00 -54.4%N/A0.1 $2.27 8/31/2020136,700 shares $263,831.00 -75.6%N/A0.2 $1.93 8/14/2020560,200 shares $1.28 million -0.7%N/A0.5 $2.28 7/31/2020564,400 shares $1.41 million -12.6%N/A0.6 $2.49 7/15/2020646,000 shares $1.64 million -2.2%N/A0.7 $2.54 6/30/2020660,700 shares $1.44 million -5.6%N/A0.7 $2.18 6/15/2020699,700 shares $1.36 million +14.4%N/A0.7 $1.95 5/29/2020611,500 shares $776,605.00 -3.0%N/A0.7 $1.27 5/15/2020630,300 shares $945,450.00 +25.4%N/A0.6 $1.50 4/30/2020502,800 shares $799,452.00 +130.4%N/A0.6 $1.59 4/15/2020218,200 shares $235,656.00 +75.3%N/A0.3 $1.08 3/31/2020124,500 shares $170,565.00 -35.7%N/A0.2 $1.37 3/13/2020193,500 shares $179,955.00 +10.8%N/A0.1 $0.93 2/28/2020174,700 shares $122,290.00 +24.0%N/A0.4 $0.70 2/14/2020140,900 shares $142,309.00 +4.5%N/A1 $1.01 1/31/2020134,900 shares $128,155.00 +12.4%N/A1.1 $0.95 1/15/2020120,000 shares $132,000.00 +1.7%N/A1.3 $1.10 12/31/2019118,000 shares $146,320.00 -3.5%N/A1.7 $1.24 TRIB Short Interest - Frequently Asked Questions What is Trinity Biotech's current short interest? Short interest is the volume of Trinity Biotech shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 94,100 shares of TRIB short. 0.86% of Trinity Biotech's shares are currently sold short. Learn More on Trinity Biotech's current short interest. What is a good short interest percentage for Trinity Biotech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.86% of Trinity Biotech's floating shares are currently sold short. Is Trinity Biotech's short interest increasing or decreasing? Trinity Biotech saw a decrease in short interest in the month of October. As of October 31st, there was short interest totaling 94,100 shares, a decrease of 23.1% from the previous total of 122,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Trinity Biotech's float size? Trinity Biotech currently has issued a total of 7,620,000 shares. Some of Trinity Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Trinity Biotech currently has a public float of 10,960,000 shares. How does Trinity Biotech's short interest compare to its competitors? 0.86% of Trinity Biotech's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Trinity Biotech: Anebulo Pharmaceuticals, Inc. (0.12%), LAVA Therapeutics (0.13%), RAPT Therapeutics, Inc. (7.64%), CERo Therapeutics Holdings, Inc. (3.91%), Lumos Pharma, Inc. (1.54%), NextCure, Inc. (0.31%), OKYO Pharma Limited (1.11%), Carisma Therapeutics, Inc. (4.00%), HCW Biologics Inc. (0.04%), Barinthus Biotherapeutics plc (0.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Trinity Biotech stock? Short selling TRIB is an investing strategy that aims to generate trading profit from Trinity Biotech as its price is falling. TRIB shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Trinity Biotech? A short squeeze for Trinity Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TRIB, which in turn drives the price of the stock up even further. How often is Trinity Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TRIB, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Rallybio Short Interest Data Anebulo Pharmaceuticals Short Interest Data Clene Short Interest Data CERo Therapeutics Short Interest Data Lumos Pharma Short Interest Data RAPT Therapeutics Short Interest Data NextCure Short Interest Data Carisma Therapeutics Short Interest Data Dyadic International Short Interest Data Barinthus Biotherapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TRIB) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | SponsoredJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purpose...Priority Gold | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredTrump said you could learn something from this manEarly Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide vic...Wide Moat Research | SponsoredThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of ...WealthPress | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trinity Biotech plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Trinity Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.